StonvexLoading…
StonvexStonvexStonvexCore line items from ENVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $875.14M | $3.15B | $2.31B | $1.51B |
Operating Income | $207.11M | $739.43M | $552.78M | $356.01M |
Net Income | $91.10M | $308.39M | $229.41M | $149.09M |
EPS (Diluted) | $3.46 | $11.52 | $8.53 | $5.51 |
Total Assets | $6.88B | $6.47B | $5.96B | $5.72B |
Total Liabilities | $5.48B | $5.13B | $4.68B | $4.50B |
Cash & Equivalents | $96.13M | $71.71M | $53.60M | $55.56M |
Free Cash Flow OCF − CapEx | $463.79M | $1.77B | $1.28B | $814.41M |
Shares Outstanding | 24.92M | 24.72M | 24.88M | 25.07M |